静脈血栓塞栓症治療のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Venous Thromboembolism Therapy Market Insights, Forecast to 2028

• レポートコード：QY2203B11518 • 出版社/出版日：QYResearch / 2022年3月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療装置

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の静脈血栓塞栓症治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に静脈血栓塞栓症治療の世界市場のxxx％を占める「非セグメント化空気圧迫ポンプ」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の静脈血栓塞栓症治療の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの静脈血栓塞栓症治療市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの静脈血栓塞栓症治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 静脈血栓塞栓症治療のグローバル主要メーカーには、Medtronic、Boston Scientific、Stryker、AngioDynamics、Cook Medical、Cardinal Health、DJO Global、Philips Holding、ArjoHuntleigh AB、Argon Medical Devices、DaeSung Maref、ALN Implants Chirurgicaux、Lifetech Scientificなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 静脈血栓塞栓症治療市場は、種類と用途によって区分されます。世界の静脈血栓塞栓症治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 非セグメント化空気圧迫ポンプ、グラジエント無しセグメント化空気圧圧縮ポンプ 【用途別セグメント】 病院、クリニック、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 静脈血栓塞栓症治療製品概要 - 種類別市場（非セグメント化空気圧迫ポンプ、グラジエント無しセグメント化空気圧圧縮ポンプ） - 用途別市場（病院、クリニック、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の静脈血栓塞栓症治療販売量予測2017-2028 - 世界の静脈血栓塞栓症治療売上予測2017-2028 - 静脈血栓塞栓症治療の地域別販売量 - 静脈血栓塞栓症治療の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別静脈血栓塞栓症治療販売量 - 主要メーカー別静脈血栓塞栓症治療売上 - 主要メーカー別静脈血栓塞栓症治療価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（非セグメント化空気圧迫ポンプ、グラジエント無しセグメント化空気圧圧縮ポンプ） - 静脈血栓塞栓症治療の種類別販売量 - 静脈血栓塞栓症治療の種類別売上 - 静脈血栓塞栓症治療の種類別価格 ・用途別市場規模（病院、クリニック、その他） - 静脈血栓塞栓症治療の用途別販売量 - 静脈血栓塞栓症治療の用途別売上 - 静脈血栓塞栓症治療の用途別価格 ・北米市場 - 北米の静脈血栓塞栓症治療市場規模（種類別、用途別） - 主要国別の静脈血栓塞栓症治療市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの静脈血栓塞栓症治療市場規模（種類別、用途別） - 主要国別の静脈血栓塞栓症治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の静脈血栓塞栓症治療市場規模（種類別、用途別） - 主要国別の静脈血栓塞栓症治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の静脈血栓塞栓症治療市場規模（種類別、用途別） - 主要国別の静脈血栓塞栓症治療市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの静脈血栓塞栓症治療市場規模（種類別、用途別） - 主要国別の静脈血栓塞栓症治療市場規模（トルコ、サウジアラビア） ・企業情報 Medtronic、Boston Scientific、Stryker、AngioDynamics、Cook Medical、Cardinal Health、DJO Global、Philips Holding、ArjoHuntleigh AB、Argon Medical Devices、DaeSung Maref、ALN Implants Chirurgicaux、Lifetech Scientific ・産業チェーン及び販売チャネル分析 - 静脈血栓塞栓症治療の産業チェーン分析 - 静脈血栓塞栓症治療の原材料 - 静脈血栓塞栓症治療の生産プロセス - 静脈血栓塞栓症治療の販売及びマーケティング - 静脈血栓塞栓症治療の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 静脈血栓塞栓症治療の産業動向 - 静脈血栓塞栓症治療のマーケットドライバー - 静脈血栓塞栓症治療の課題 - 静脈血栓塞栓症治療の阻害要因 ・主な調査結果

A venous thrombus is a blood clot (thrombus) that forms within a vein. Thrombosis is a term for a blood clot occurring inside a blood vessel. A common type of venous thrombosis is a deep vein thrombosis (DVT), which is a blood clot in the deep veins of the leg. If the thrombus breaks off (embolizes) and flows towards the lungs, it can become a pulmonary embolism (PE), a blood clot in the lungs.
Market Analysis and Insights: Global Venous Thromboembolism Therapy Market
Due to the COVID-19 pandemic, the global Venous Thromboembolism Therapy market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Non-Segmented Pneumatic Compression Pumps accounting for % of the Venous Thromboembolism Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Venous Thromboembolism Therapy market size is valued at US$ million in 2021, while the US and Europe Venous Thromboembolism Therapy are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Venous Thromboembolism Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Venous Thromboembolism Therapy include Medtronic, Boston Scientific, Stryker, AngioDynamics, Cook Medical, Cardinal Health, DJO Global, Philips Holding and ArjoHuntleigh AB, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Venous Thromboembolism Therapy Scope and Segment
Venous Thromboembolism Therapy market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Venous Thromboembolism Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Non-Segmented Pneumatic Compression Pumps
Segmented Pneumatic Compression Pumps without Gradient
Segment by Application
Hospitals
Clinics
Others
By Company
Medtronic
Boston Scientific
Stryker
AngioDynamics
Cook Medical
Cardinal Health
DJO Global
Philips Holding
ArjoHuntleigh AB
Argon Medical Devices
DaeSung Maref
ALN Implants Chirurgicaux
Lifetech Scientific
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Venous Thromboembolism Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Venous Thromboembolism Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Non-Segmented Pneumatic Compression Pumps
1.2.3 Segmented Pneumatic Compression Pumps without Gradient
1.3 Market by Application
1.3.1 Global Venous Thromboembolism Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Venous Thromboembolism Therapy Sales Estimates and Forecasts 2017-2028
2.2 Global Venous Thromboembolism Therapy Revenue Estimates and Forecasts 2017-2028
2.3 Global Venous Thromboembolism Therapy Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Venous Thromboembolism Therapy Sales by Region
2.4.1 Global Venous Thromboembolism Therapy Sales by Region (2017-2022)
2.4.2 Global Sales Venous Thromboembolism Therapy by Region (2023-2028)
2.5 Global Venous Thromboembolism Therapy Revenue by Region
2.5.1 Global Venous Thromboembolism Therapy Revenue by Region (2017-2022)
2.5.2 Global Venous Thromboembolism Therapy Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Venous Thromboembolism Therapy Sales by Manufacturers
3.1.1 Global Top Venous Thromboembolism Therapy Manufacturers by Sales (2017-2022)
3.1.2 Global Venous Thromboembolism Therapy Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Venous Thromboembolism Therapy in 2021
3.2 Global Venous Thromboembolism Therapy Revenue by Manufacturers
3.2.1 Global Venous Thromboembolism Therapy Revenue by Manufacturers (2017-2022)
3.2.2 Global Venous Thromboembolism Therapy Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Venous Thromboembolism Therapy Revenue in 2021
3.3 Global Venous Thromboembolism Therapy Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Venous Thromboembolism Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Venous Thromboembolism Therapy Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Venous Thromboembolism Therapy Sales by Type
4.1.1 Global Venous Thromboembolism Therapy Historical Sales by Type (2017-2022)
4.1.2 Global Venous Thromboembolism Therapy Forecasted Sales by Type (2023-2028)
4.1.3 Global Venous Thromboembolism Therapy Sales Market Share by Type (2017-2028)
4.2 Global Venous Thromboembolism Therapy Revenue by Type
4.2.1 Global Venous Thromboembolism Therapy Historical Revenue by Type (2017-2022)
4.2.2 Global Venous Thromboembolism Therapy Forecasted Revenue by Type (2023-2028)
4.2.3 Global Venous Thromboembolism Therapy Revenue Market Share by Type (2017-2028)
4.3 Global Venous Thromboembolism Therapy Price by Type
4.3.1 Global Venous Thromboembolism Therapy Price by Type (2017-2022)
4.3.2 Global Venous Thromboembolism Therapy Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Venous Thromboembolism Therapy Sales by Application
5.1.1 Global Venous Thromboembolism Therapy Historical Sales by Application (2017-2022)
5.1.2 Global Venous Thromboembolism Therapy Forecasted Sales by Application (2023-2028)
5.1.3 Global Venous Thromboembolism Therapy Sales Market Share by Application (2017-2028)
5.2 Global Venous Thromboembolism Therapy Revenue by Application
5.2.1 Global Venous Thromboembolism Therapy Historical Revenue by Application (2017-2022)
5.2.2 Global Venous Thromboembolism Therapy Forecasted Revenue by Application (2023-2028)
5.2.3 Global Venous Thromboembolism Therapy Revenue Market Share by Application (2017-2028)
5.3 Global Venous Thromboembolism Therapy Price by Application
5.3.1 Global Venous Thromboembolism Therapy Price by Application (2017-2022)
5.3.2 Global Venous Thromboembolism Therapy Price Forecast by Application (2023-2028)
6 North America
6.1 North America Venous Thromboembolism Therapy Market Size by Type
6.1.1 North America Venous Thromboembolism Therapy Sales by Type (2017-2028)
6.1.2 North America Venous Thromboembolism Therapy Revenue by Type (2017-2028)
6.2 North America Venous Thromboembolism Therapy Market Size by Application
6.2.1 North America Venous Thromboembolism Therapy Sales by Application (2017-2028)
6.2.2 North America Venous Thromboembolism Therapy Revenue by Application (2017-2028)
6.3 North America Venous Thromboembolism Therapy Market Size by Country
6.3.1 North America Venous Thromboembolism Therapy Sales by Country (2017-2028)
6.3.2 North America Venous Thromboembolism Therapy Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Venous Thromboembolism Therapy Market Size by Type
7.1.1 Europe Venous Thromboembolism Therapy Sales by Type (2017-2028)
7.1.2 Europe Venous Thromboembolism Therapy Revenue by Type (2017-2028)
7.2 Europe Venous Thromboembolism Therapy Market Size by Application
7.2.1 Europe Venous Thromboembolism Therapy Sales by Application (2017-2028)
7.2.2 Europe Venous Thromboembolism Therapy Revenue by Application (2017-2028)
7.3 Europe Venous Thromboembolism Therapy Market Size by Country
7.3.1 Europe Venous Thromboembolism Therapy Sales by Country (2017-2028)
7.3.2 Europe Venous Thromboembolism Therapy Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Venous Thromboembolism Therapy Market Size by Type
8.1.1 Asia Pacific Venous Thromboembolism Therapy Sales by Type (2017-2028)
8.1.2 Asia Pacific Venous Thromboembolism Therapy Revenue by Type (2017-2028)
8.2 Asia Pacific Venous Thromboembolism Therapy Market Size by Application
8.2.1 Asia Pacific Venous Thromboembolism Therapy Sales by Application (2017-2028)
8.2.2 Asia Pacific Venous Thromboembolism Therapy Revenue by Application (2017-2028)
8.3 Asia Pacific Venous Thromboembolism Therapy Market Size by Region
8.3.1 Asia Pacific Venous Thromboembolism Therapy Sales by Region (2017-2028)
8.3.2 Asia Pacific Venous Thromboembolism Therapy Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Venous Thromboembolism Therapy Market Size by Type
9.1.1 Latin America Venous Thromboembolism Therapy Sales by Type (2017-2028)
9.1.2 Latin America Venous Thromboembolism Therapy Revenue by Type (2017-2028)
9.2 Latin America Venous Thromboembolism Therapy Market Size by Application
9.2.1 Latin America Venous Thromboembolism Therapy Sales by Application (2017-2028)
9.2.2 Latin America Venous Thromboembolism Therapy Revenue by Application (2017-2028)
9.3 Latin America Venous Thromboembolism Therapy Market Size by Country
9.3.1 Latin America Venous Thromboembolism Therapy Sales by Country (2017-2028)
9.3.2 Latin America Venous Thromboembolism Therapy Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Venous Thromboembolism Therapy Market Size by Type
10.1.1 Middle East and Africa Venous Thromboembolism Therapy Sales by Type (2017-2028)
10.1.2 Middle East and Africa Venous Thromboembolism Therapy Revenue by Type (2017-2028)
10.2 Middle East and Africa Venous Thromboembolism Therapy Market Size by Application
10.2.1 Middle East and Africa Venous Thromboembolism Therapy Sales by Application (2017-2028)
10.2.2 Middle East and Africa Venous Thromboembolism Therapy Revenue by Application (2017-2028)
10.3 Middle East and Africa Venous Thromboembolism Therapy Market Size by Country
10.3.1 Middle East and Africa Venous Thromboembolism Therapy Sales by Country (2017-2028)
10.3.2 Middle East and Africa Venous Thromboembolism Therapy Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Overview
11.1.3 Medtronic Venous Thromboembolism Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Medtronic Venous Thromboembolism Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Medtronic Recent Developments
11.2 Boston Scientific
11.2.1 Boston Scientific Corporation Information
11.2.2 Boston Scientific Overview
11.2.3 Boston Scientific Venous Thromboembolism Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Boston Scientific Venous Thromboembolism Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Boston Scientific Recent Developments
11.3 Stryker
11.3.1 Stryker Corporation Information
11.3.2 Stryker Overview
11.3.3 Stryker Venous Thromboembolism Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Stryker Venous Thromboembolism Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Stryker Recent Developments
11.4 AngioDynamics
11.4.1 AngioDynamics Corporation Information
11.4.2 AngioDynamics Overview
11.4.3 AngioDynamics Venous Thromboembolism Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 AngioDynamics Venous Thromboembolism Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 AngioDynamics Recent Developments
11.5 Cook Medical
11.5.1 Cook Medical Corporation Information
11.5.2 Cook Medical Overview
11.5.3 Cook Medical Venous Thromboembolism Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Cook Medical Venous Thromboembolism Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Cook Medical Recent Developments
11.6 Cardinal Health
11.6.1 Cardinal Health Corporation Information
11.6.2 Cardinal Health Overview
11.6.3 Cardinal Health Venous Thromboembolism Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Cardinal Health Venous Thromboembolism Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Cardinal Health Recent Developments
11.7 DJO Global
11.7.1 DJO Global Corporation Information
11.7.2 DJO Global Overview
11.7.3 DJO Global Venous Thromboembolism Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 DJO Global Venous Thromboembolism Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 DJO Global Recent Developments
11.8 Philips Holding
11.8.1 Philips Holding Corporation Information
11.8.2 Philips Holding Overview
11.8.3 Philips Holding Venous Thromboembolism Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Philips Holding Venous Thromboembolism Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Philips Holding Recent Developments
11.9 ArjoHuntleigh AB
11.9.1 ArjoHuntleigh AB Corporation Information
11.9.2 ArjoHuntleigh AB Overview
11.9.3 ArjoHuntleigh AB Venous Thromboembolism Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 ArjoHuntleigh AB Venous Thromboembolism Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 ArjoHuntleigh AB Recent Developments
11.10 Argon Medical Devices
11.10.1 Argon Medical Devices Corporation Information
11.10.2 Argon Medical Devices Overview
11.10.3 Argon Medical Devices Venous Thromboembolism Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Argon Medical Devices Venous Thromboembolism Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Argon Medical Devices Recent Developments
11.11 DaeSung Maref
11.11.1 DaeSung Maref Corporation Information
11.11.2 DaeSung Maref Overview
11.11.3 DaeSung Maref Venous Thromboembolism Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 DaeSung Maref Venous Thromboembolism Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 DaeSung Maref Recent Developments
11.12 ALN Implants Chirurgicaux
11.12.1 ALN Implants Chirurgicaux Corporation Information
11.12.2 ALN Implants Chirurgicaux Overview
11.12.3 ALN Implants Chirurgicaux Venous Thromboembolism Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 ALN Implants Chirurgicaux Venous Thromboembolism Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 ALN Implants Chirurgicaux Recent Developments
11.13 Lifetech Scientific
11.13.1 Lifetech Scientific Corporation Information
11.13.2 Lifetech Scientific Overview
11.13.3 Lifetech Scientific Venous Thromboembolism Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Lifetech Scientific Venous Thromboembolism Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Lifetech Scientific Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Venous Thromboembolism Therapy Industry Chain Analysis
12.2 Venous Thromboembolism Therapy Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Venous Thromboembolism Therapy Production Mode & Process
12.4 Venous Thromboembolism Therapy Sales and Marketing
12.4.1 Venous Thromboembolism Therapy Sales Channels
12.4.2 Venous Thromboembolism Therapy Distributors
12.5 Venous Thromboembolism Therapy Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Venous Thromboembolism Therapy Industry Trends
13.2 Venous Thromboembolism Therapy Market Drivers
13.3 Venous Thromboembolism Therapy Market Challenges
13.4 Venous Thromboembolism Therapy Market Restraints
14 Key Findings in The Global Venous Thromboembolism Therapy Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Venous Thromboembolism Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Non-Segmented Pneumatic Compression Pumps
Table 3. Major Manufacturers of Segmented Pneumatic Compression Pumps without Gradient
Table 4. Global Venous Thromboembolism Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Venous Thromboembolism Therapy Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Venous Thromboembolism Therapy Sales by Region (2017-2022) & (K Units)
Table 7. Global Venous Thromboembolism Therapy Sales Market Share by Region (2017-2022)
Table 8. Global Venous Thromboembolism Therapy Sales by Region (2023-2028) & (K Units)
Table 9. Global Venous Thromboembolism Therapy Sales Market Share by Region (2023-2028)
Table 10. Global Venous Thromboembolism Therapy Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Venous Thromboembolism Therapy Revenue Market Share by Region (2017-2022)
Table 12. Global Venous Thromboembolism Therapy Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Venous Thromboembolism Therapy Revenue Market Share by Region (2023-2028)
Table 14. Global Venous Thromboembolism Therapy Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Venous Thromboembolism Therapy Sales Share by Manufacturers (2017-2022)
Table 16. Global Venous Thromboembolism Therapy Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Venous Thromboembolism Therapy Revenue Share by Manufacturers (2017-2022)
Table 18. Venous Thromboembolism Therapy Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Venous Thromboembolism Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Venous Thromboembolism Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Venous Thromboembolism Therapy as of 2021)
Table 21. Venous Thromboembolism Therapy Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Venous Thromboembolism Therapy Product Offered
Table 23. Date of Manufacturers Enter into Venous Thromboembolism Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Venous Thromboembolism Therapy Sales by Type (2017-2022) & (K Units)
Table 26. Global Venous Thromboembolism Therapy Sales by Type (2023-2028) & (K Units)
Table 27. Global Venous Thromboembolism Therapy Sales Share by Type (2017-2022)
Table 28. Global Venous Thromboembolism Therapy Sales Share by Type (2023-2028)
Table 29. Global Venous Thromboembolism Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Venous Thromboembolism Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Venous Thromboembolism Therapy Revenue Share by Type (2017-2022)
Table 32. Global Venous Thromboembolism Therapy Revenue Share by Type (2023-2028)
Table 33. Venous Thromboembolism Therapy Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Venous Thromboembolism Therapy Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Venous Thromboembolism Therapy Sales by Application (2017-2022) & (K Units)
Table 36. Global Venous Thromboembolism Therapy Sales by Application (2023-2028) & (K Units)
Table 37. Global Venous Thromboembolism Therapy Sales Share by Application (2017-2022)
Table 38. Global Venous Thromboembolism Therapy Sales Share by Application (2023-2028)
Table 39. Global Venous Thromboembolism Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Venous Thromboembolism Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Venous Thromboembolism Therapy Revenue Share by Application (2017-2022)
Table 42. Global Venous Thromboembolism Therapy Revenue Share by Application (2023-2028)
Table 43. Venous Thromboembolism Therapy Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Venous Thromboembolism Therapy Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Venous Thromboembolism Therapy Sales by Type (2017-2022) & (K Units)
Table 46. North America Venous Thromboembolism Therapy Sales by Type (2023-2028) & (K Units)
Table 47. North America Venous Thromboembolism Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Venous Thromboembolism Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Venous Thromboembolism Therapy Sales by Application (2017-2022) & (K Units)
Table 50. North America Venous Thromboembolism Therapy Sales by Application (2023-2028) & (K Units)
Table 51. North America Venous Thromboembolism Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Venous Thromboembolism Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Venous Thromboembolism Therapy Sales by Country (2017-2022) & (K Units)
Table 54. North America Venous Thromboembolism Therapy Sales by Country (2023-2028) & (K Units)
Table 55. North America Venous Thromboembolism Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Venous Thromboembolism Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Venous Thromboembolism Therapy Sales by Type (2017-2022) & (K Units)
Table 58. Europe Venous Thromboembolism Therapy Sales by Type (2023-2028) & (K Units)
Table 59. Europe Venous Thromboembolism Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Venous Thromboembolism Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Venous Thromboembolism Therapy Sales by Application (2017-2022) & (K Units)
Table 62. Europe Venous Thromboembolism Therapy Sales by Application (2023-2028) & (K Units)
Table 63. Europe Venous Thromboembolism Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Venous Thromboembolism Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Venous Thromboembolism Therapy Sales by Country (2017-2022) & (K Units)
Table 66. Europe Venous Thromboembolism Therapy Sales by Country (2023-2028) & (K Units)
Table 67. Europe Venous Thromboembolism Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Venous Thromboembolism Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Venous Thromboembolism Therapy Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Venous Thromboembolism Therapy Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Venous Thromboembolism Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Venous Thromboembolism Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Venous Thromboembolism Therapy Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Venous Thromboembolism Therapy Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Venous Thromboembolism Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Venous Thromboembolism Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Venous Thromboembolism Therapy Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Venous Thromboembolism Therapy Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Venous Thromboembolism Therapy Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Venous Thromboembolism Therapy Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Venous Thromboembolism Therapy Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Venous Thromboembolism Therapy Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Venous Thromboembolism Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Venous Thromboembolism Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Venous Thromboembolism Therapy Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Venous Thromboembolism Therapy Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Venous Thromboembolism Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Venous Thromboembolism Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Venous Thromboembolism Therapy Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Venous Thromboembolism Therapy Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Venous Thromboembolism Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Venous Thromboembolism Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Venous Thromboembolism Therapy Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Venous Thromboembolism Therapy Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Venous Thromboembolism Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Venous Thromboembolism Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Venous Thromboembolism Therapy Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Venous Thromboembolism Therapy Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Venous Thromboembolism Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Venous Thromboembolism Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Venous Thromboembolism Therapy Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Venous Thromboembolism Therapy Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Venous Thromboembolism Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Venous Thromboembolism Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 105. Medtronic Corporation Information
Table 106. Medtronic Description and Major Businesses
Table 107. Medtronic Venous Thromboembolism Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Medtronic Venous Thromboembolism Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Medtronic Recent Developments
Table 110. Boston Scientific Corporation Information
Table 111. Boston Scientific Description and Major Businesses
Table 112. Boston Scientific Venous Thromboembolism Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Boston Scientific Venous Thromboembolism Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Boston Scientific Recent Developments
Table 115. Stryker Corporation Information
Table 116. Stryker Description and Major Businesses
Table 117. Stryker Venous Thromboembolism Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Stryker Venous Thromboembolism Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Stryker Recent Developments
Table 120. AngioDynamics Corporation Information
Table 121. AngioDynamics Description and Major Businesses
Table 122. AngioDynamics Venous Thromboembolism Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. AngioDynamics Venous Thromboembolism Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. AngioDynamics Recent Developments
Table 125. Cook Medical Corporation Information
Table 126. Cook Medical Description and Major Businesses
Table 127. Cook Medical Venous Thromboembolism Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Cook Medical Venous Thromboembolism Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Cook Medical Recent Developments
Table 130. Cardinal Health Corporation Information
Table 131. Cardinal Health Description and Major Businesses
Table 132. Cardinal Health Venous Thromboembolism Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Cardinal Health Venous Thromboembolism Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Cardinal Health Recent Developments
Table 135. DJO Global Corporation Information
Table 136. DJO Global Description and Major Businesses
Table 137. DJO Global Venous Thromboembolism Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. DJO Global Venous Thromboembolism Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. DJO Global Recent Developments
Table 140. Philips Holding Corporation Information
Table 141. Philips Holding Description and Major Businesses
Table 142. Philips Holding Venous Thromboembolism Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Philips Holding Venous Thromboembolism Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Philips Holding Recent Developments
Table 145. ArjoHuntleigh AB Corporation Information
Table 146. ArjoHuntleigh AB Description and Major Businesses
Table 147. ArjoHuntleigh AB Venous Thromboembolism Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. ArjoHuntleigh AB Venous Thromboembolism Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. ArjoHuntleigh AB Recent Developments
Table 150. Argon Medical Devices Corporation Information
Table 151. Argon Medical Devices Description and Major Businesses
Table 152. Argon Medical Devices Venous Thromboembolism Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. Argon Medical Devices Venous Thromboembolism Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Argon Medical Devices Recent Developments
Table 155. DaeSung Maref Corporation Information
Table 156. DaeSung Maref Description and Major Businesses
Table 157. DaeSung Maref Venous Thromboembolism Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 158. DaeSung Maref Venous Thromboembolism Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. DaeSung Maref Recent Developments
Table 160. ALN Implants Chirurgicaux Corporation Information
Table 161. ALN Implants Chirurgicaux Description and Major Businesses
Table 162. ALN Implants Chirurgicaux Venous Thromboembolism Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 163. ALN Implants Chirurgicaux Venous Thromboembolism Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. ALN Implants Chirurgicaux Recent Developments
Table 165. Lifetech Scientific Corporation Information
Table 166. Lifetech Scientific Description and Major Businesses
Table 167. Lifetech Scientific Venous Thromboembolism Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 168. Lifetech Scientific Venous Thromboembolism Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Lifetech Scientific Recent Developments
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Venous Thromboembolism Therapy Distributors List
Table 173. Venous Thromboembolism Therapy Customers List
Table 174. Venous Thromboembolism Therapy Market Trends
Table 175. Venous Thromboembolism Therapy Market Drivers
Table 176. Venous Thromboembolism Therapy Market Challenges
Table 177. Venous Thromboembolism Therapy Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Venous Thromboembolism Therapy Product Picture
Figure 3. Global Venous Thromboembolism Therapy Market Share by Type in 2021 & 2028
Figure 3. Non-Segmented Pneumatic Compression Pumps Product Picture
Figure 4. Segmented Pneumatic Compression Pumps without Gradient Product Picture
Figure 5. Global Venous Thromboembolism Therapy Market Share by Application in 2021 & 2028
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Others
Figure 9. Venous Thromboembolism Therapy Report Years Considered
Figure 10. Global Venous Thromboembolism Therapy Sales 2017-2028 (K Units)
Figure 11. Global Venous Thromboembolism Therapy Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Venous Thromboembolism Therapy Revenue 2017-2028 (US$ Million)
Figure 13. Global Venous Thromboembolism Therapy Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Venous Thromboembolism Therapy Sales Market Share by Region (2017-2022)
Figure 15. Global Venous Thromboembolism Therapy Sales Market Share by Region (2023-2028)
Figure 16. North America Venous Thromboembolism Therapy Sales YoY (2017-2028) & (K Units)
Figure 17. North America Venous Thromboembolism Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Venous Thromboembolism Therapy Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Venous Thromboembolism Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Venous Thromboembolism Therapy Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Venous Thromboembolism Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Venous Thromboembolism Therapy Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Venous Thromboembolism Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Venous Thromboembolism Therapy Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Venous Thromboembolism Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Venous Thromboembolism Therapy Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Venous Thromboembolism Therapy in the World: Market Share by Venous Thromboembolism Therapy Revenue in 2021
Figure 28. Global Venous Thromboembolism Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Venous Thromboembolism Therapy Sales Market Share by Type (2017-2028)
Figure 30. Global Venous Thromboembolism Therapy Revenue Market Share by Type (2017-2028)
Figure 31. Global Venous Thromboembolism Therapy Sales Market Share by Application (2017-2028)
Figure 32. Global Venous Thromboembolism Therapy Revenue Market Share by Application (2017-2028)
Figure 33. North America Venous Thromboembolism Therapy Sales Market Share by Type (2017-2028)
Figure 34. North America Venous Thromboembolism Therapy Revenue Market Share by Type (2017-2028)
Figure 35. North America Venous Thromboembolism Therapy Sales Market Share by Application (2017-2028)
Figure 36. North America Venous Thromboembolism Therapy Revenue Market Share by Application (2017-2028)
Figure 37. North America Venous Thromboembolism Therapy Sales Share by Country (2017-2028)
Figure 38. North America Venous Thromboembolism Therapy Revenue Share by Country (2017-2028)
Figure 39. United States Venous Thromboembolism Therapy Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Venous Thromboembolism Therapy Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Venous Thromboembolism Therapy Sales Market Share by Type (2017-2028)
Figure 42. Europe Venous Thromboembolism Therapy Revenue Market Share by Type (2017-2028)
Figure 43. Europe Venous Thromboembolism Therapy Sales Market Share by Application (2017-2028)
Figure 44. Europe Venous Thromboembolism Therapy Revenue Market Share by Application (2017-2028)
Figure 45. Europe Venous Thromboembolism Therapy Sales Share by Country (2017-2028)
Figure 46. Europe Venous Thromboembolism Therapy Revenue Share by Country (2017-2028)
Figure 47. Germany Venous Thromboembolism Therapy Revenue (2017-2028) & (US$ Million)
Figure 48. France Venous Thromboembolism Therapy Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Venous Thromboembolism Therapy Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Venous Thromboembolism Therapy Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Venous Thromboembolism Therapy Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Venous Thromboembolism Therapy Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Venous Thromboembolism Therapy Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Venous Thromboembolism Therapy Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Venous Thromboembolism Therapy Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Venous Thromboembolism Therapy Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Venous Thromboembolism Therapy Revenue Share by Region (2017-2028)
Figure 58. China Venous Thromboembolism Therapy Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Venous Thromboembolism Therapy Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Venous Thromboembolism Therapy Revenue (2017-2028) & (US$ Million)
Figure 61. India Venous Thromboembolism Therapy Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Venous Thromboembolism Therapy Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Venous Thromboembolism Therapy Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Venous Thromboembolism Therapy Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Venous Thromboembolism Therapy Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Venous Thromboembolism Therapy Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Venous Thromboembolism Therapy Sales Market Share by Type (2017-2028)
Figure 68. Latin America Venous Thromboembolism Therapy Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Venous Thromboembolism Therapy Sales Market Share by Application (2017-2028)
Figure 70. Latin America Venous Thromboembolism Therapy Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Venous Thromboembolism Therapy Sales Share by Country (2017-2028)
Figure 72. Latin America Venous Thromboembolism Therapy Revenue Share by Country (2017-2028)
Figure 73. Mexico Venous Thromboembolism Therapy Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Venous Thromboembolism Therapy Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Venous Thromboembolism Therapy Revenue (2017-2028) & (US$ Million)
Figure 76. Colombia Venous Thromboembolism Therapy Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Venous Thromboembolism Therapy Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Venous Thromboembolism Therapy Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Venous Thromboembolism Therapy Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Venous Thromboembolism Therapy Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Venous Thromboembolism Therapy Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Venous Thromboembolism Therapy Revenue Share by Country (2017-2028)
Figure 83. Turkey Venous Thromboembolism Therapy Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Venous Thromboembolism Therapy Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Venous Thromboembolism Therapy Revenue (2017-2028) & (US$ Million)
Figure 86. Venous Thromboembolism Therapy Value Chain
Figure 87. Venous Thromboembolism Therapy Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---